Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 8(1): 10346, 2018 07 09.
Article in English | MEDLINE | ID: mdl-29985461

ABSTRACT

The purpose of this study was to study whether complement depletion induced by pretreatment with Cobra Venom Factor (CVF) could protect against lung ischemia reperfusion injury (LIRI) in a rat model and explore its molecular mechanisms. Adult Sprague-Dawley rats were randomly assigned to five groups (n = 6): Control group, Sham-operated group, I/R group, CVF group, I/R + CVF group. CVF (50 µg/kg) was injected through the tail vein 24 h before anesthesia. Lung ischemia reperfusion (I/R) was induced by clamping the left hilus pulmonis for 60 minutes followed by 4 hours of reperfusion. Measurement of complement activity, pathohistological lung injury score, inflammatory mediators, pulmonary permeability, pulmonary edema, integrity of tight junction and blood-air barrier were performed. The results showed that pretreatment with CVF significantly reduced complement activity in plasma and BALF. Evaluation in histomorphology showed that complement depletion induced by CVF significantly alleviated the damage of lung tissues and inhibited inflammatory response in lung tissues and BALF. Furthermore, CVF pretreatment had the function of ameliorating pulmonary permeability and preserving integrity of tight junctions in IR condition. In conclusion, our results indicated that complement depletion induced by CVF could inhibit I/R-induced inflammatory response and alleviate lung I/R injury. The mechanisms of its protective effects might be ameliorated blood-air barrier damage.


Subject(s)
Blood-Air Barrier/drug effects , Complement System Proteins/metabolism , Elapid Venoms/pharmacology , Protective Agents/pharmacology , Reperfusion Injury/pathology , Animals , Blood-Air Barrier/metabolism , Bronchoalveolar Lavage Fluid/chemistry , Complement System Proteins/deficiency , Cytokines/metabolism , Disease Models, Animal , Elapid Venoms/therapeutic use , Inflammation Mediators/metabolism , Lung/drug effects , Lung/metabolism , Lung/pathology , Permeability/drug effects , Protective Agents/therapeutic use , Pulmonary Veins/metabolism , Rats , Rats, Sprague-Dawley , Reperfusion Injury/prevention & control , Tight Junctions/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...